Reference curves for aggregation and ATP secretion to aid diagnose of platelet-based bleeding disorders: Effect of inhibition of ADP and thromboxane A2 pathways

Platelets

Volumn 18, Issue 5, 2007, Pages 329-345

  Dawood, Ban B ^a   Wilde, Jonathan ^b   Watson, Steve P ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

ADP receptors; Dense granule secretion; Patient testing; Platelets aggregation; Thromboxane A2

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 2' DEOXY 6 N METHYLADENOSINE 3',5' BISPHOSPHATE; ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ADRENALIN; ALANYLTYROSYLPROLYLGLYCYLLYSYLPHENYLALANINE; BETA,GAMMA DICHLOROMETHYLENE 2 PROPYLTHIOADENOSINE TRIPHOSPHATE; CYSTEINYLARGINYLPROLINE; INDOMETACIN; PROSTAGLANDIN SYNTHASE INHIBITOR; PROTEINASE ACTIVATED RECEPTOR 1; PROTEINASE ACTIVATED RECEPTOR 4; PURINE ANTAGONIST; PURINE P2Y1 RECEPTOR; PURINE P2Y12 RECEPTOR; PURINERGIC RECEPTOR BLOCKING AGENT; THROMBIN RECEPTOR ACTIVATING PEPTIDE 6; THROMBOCYTE ACTIVATING FACTOR; THROMBOCYTE SLOWING FACTOR; THROMBOXANE A2; THROMBOXANE A2 RECEPTOR BLOCKING AGENT; THROMBOXANE A2 RECEPTOR STIMULATING AGENT; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLEEDING DISORDER; BLOOD DONOR; CLINICAL LABORATORY; CONTROLLED STUDY; DIAGNOSTIC TEST; ENZYME INHIBITION; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; REPRODUCIBILITY; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOCYTE RELEASE REACTION;

ADENOSINE DIPHOSPHATE; ADENOSINE MONOPHOSPHATE; ADENOSINE TRIPHOSPHATE; BLOOD PLATELETS; CYCLOOXYGENASE INHIBITORS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HEMORRHAGE; HUMANS; INDOMETHACIN; MALE; PLATELET AGGREGATION; PLATELET FUNCTION TESTS; RECEPTORS, PURINERGIC P2; REFERENCE STANDARDS; SECRETORY VESICLES; THROMBOXANE A2;

EID: 34547170162     PISSN: 09537104     EISSN: 13691635     Source Type: Journal    
DOI: 10.1080/09537100601024111     Document Type: Article

References (15)

1. Zhou L, Schmaier AH. Platelet aggregation testing in platelet-rich plasma: Description of procedures with the aim to develop standards in the field. Am J Clin Pathol 2005;123:172-183.
2. Moffat KA, Ledford-Kraemer MR, Nichols WL, Hayward CP. Variability in clinical laboratory practice in testing for disorders of platelet function: Results of two surveys of the North American Specialized Coagulation Laboratory Association. Thromb Haemost 2005;93:549-553.
3. British Committee for Standards in Haematology. Guidelines on platelet function testing. The British Society for Haematology BCSH Haemostasis and Thrombosis Task Force. J Clin Pathol 1988;41:1322-1330.
4. Bolton-Magg PH, Chalmers EA, Collins PW, Harrison P, Kitchen S, Liesner RJ, Minford A, Mumford AD, Parapia LA, Perry DJ, Watson SP, et al. A review of inherited platelet disorders with guidelines for their management on behalf of the UKHCDO. Br J Haematol 2006. in press.
5. Woulfe DS. Platelet G protein-coupled receptors in hemostasis and thrombosis. J Thromb Haemost 2005;3:2193-2200.
6. Yee DL, Sun CW, Bergeron AL, Dong JF, Bray PF. Aggregometry detects platelet hyperreactivity in healthy individuals. Blood 2005;106:2723-2729.
7. Hayward CP, Rao AK, Cattaneo M. Congenital platelet disorders: Overview of their mechanisms, diagnostic evaluation and treatment. Haemophilia 2006;12:S128-S136.
8. Morgan NV, Pasha S, Johnson CA, Ainsworth JR, Eady RA, Dawood B, McKeown C, Trembath RC, Wilde J, Watson SP, Maher ER. A germline mutation in BLOC1S3/reduced pigmentation causes a novel variant of Hermansky-Pudlak syndrome (HPS8). Am J Hum Genet 2006;78:160-166.
9. Pozgajova M, Sachs UJ, Hein L, Nieswandt B. Reduced thrombus stability in mice lacking the {alpha}2A-adrenergic receptor. Blood 2006;108:510-514.
10. Weiss HJ, Lages B. The response of platelets to epinephrine in storage pool deficiency-evidence pertaining to the role of adenosine diphosphate in mediating primary and secondary aggregation. Blood 1988;72:1717-1725.
11. Frelinger AL 3rd, Furman MI, Linden MD, Li Y, Fox ML, Barnard MR, Michelson AD. Residual arachidonic acid-induced platelet activation via an adenosine diphosphate-dependent but cyclooxygenase-1- and cyclooxygenase-2- independent pathway: A 700-patient study of aspirin resistance. Circulation 2006;113:2888-2896.
12. Coughlin SR. Protease-activated receptors in hemostasis, thrombosis and vascular biology. J Thromb Haemost 2005;3:1800-1814.
13. Nieswandt B, Watson SP. Platelet-collagen interaction: Is GPVI the central receptor? Blood 2003;102:449-461.
14. Lecchi A, Zighetti ML, Lussana F, Cattaneo M. Platelet aggregation studies: Autologous platelet-poor plasma inhibits platelet aggregation when added to platelet-rich plasma to normalize platelet count. J Thrombosis Haemost 2005;3:S965-S965.
15. Snell DC, Schulte V, Jarvis GE, Arase K, Sakurai D, Saito T, Watson SP, Nieswandt B. Differential effects of reduced glycoprotein VI levels on activation of murine platelets by glycoprotein VI ligands. Biochem J 2002;368(Pt 1):293-300.